Double effect is a myth leading a double life [7]

British Medical Journal

Volumn 334, Issue 7591, 2007, Pages 440-

  Regnard, Claud ^a  

^a St Oswald's Hospice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OPIATE; NARCOTIC ANALGESIC AGENT;

AGITATION; CAUSE OF DEATH; DEPRESSION; DRUG EFFECT; DRUG TOLERABILITY; EUTHANASIA; EVIDENCE BASED MEDICINE; FEAR; HUMAN; LETTER; MEDICAL LITERATURE; PALLIATIVE THERAPY; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; ACTIVE EUTHANASIA; NOTE; TERMINALLY ILL PATIENT;

ANALGESICS, OPIOID; EUTHANASIA, ACTIVE; HUMANS; MORPHINE; TERMINALLY ILL;

EID: 33847792247     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Dyer C. Dying woman seeks backing to hasten death. BMJ 2007;334:329. (17 February.)
2. Morita T, Tsunoda J, Inoue S, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage 2001;21:282-9.
3. Rurup ML, Onwuteaka-Philipsen BD, van der Heide A, van der Wal G, van der Maas PJ. Trends in the agents used for euthanasia and the relationship with the number of notifications. Nederlands Tijdschrift voor Geneeskunde 2006;150:618-24.
4. Forbes K, Huxtable R. Clarifying the data on double effect. Pall Med 2006;4:395-6.